<![CDATA[Graminex® L.L.C. 보도자료 - 뉴스와이어]]>https://www.newswire.co.kr/?md=A10&act=article&no=29421>Fri, 01 May 2026 14:10:31 +0900Copyright (c) 2004~2026 Korea Newswire All rights reservedko-KR<![CDATA[GRAMINEX®, L.L.C. Final Publication of a Peer Reviewed Clinical Trial with Graminex® Flower Pollen Extract Focusing on Women’s Urinary Incontinence in Current Urology.]]>https://www.newswire.co.kr/newsRead.php?no=989704Tue, 14 May 2024 14:10:00 +0900<![CDATA[그래미넥스®, 여성의 요실금에 초점 맞춘 그래미넥스® 플라워 폴렌 익스트렉트를 사용한 동료 검토 임상 시험을 현재 비뇨기과학에 최종 발표]]>https://www.newswire.co.kr/newsRead.php?no=989706Tue, 14 May 2024 14:10:00 +0900<![CDATA[Graminex® Rye Pollen Achieves Novel Food Registration in China and Appoints Guangzhou Narnia Biotechnology as Their Authorized Distribution Partner]]>https://www.newswire.co.kr/newsRead.php?no=972027Wed, 09 Aug 2023 09:40:00 +0900<![CDATA[Graminex® 호밀 꽃가루, 중국 노블푸드 등록 및 공식 유통 파트너 광저우 나니아 바이오테크놀로지 지정]]>https://www.newswire.co.kr/newsRead.php?no=972028Wed, 09 Aug 2023 09:40:00 +0900<![CDATA[Graminex®, L.L.C. Completes Clinical Trial with Graminex® Flower Pollen Extract Focusing on Women’s Urinary Incontinence with Positive Results.]]>https://www.newswire.co.kr/newsRead.php?no=948930Tue, 02 Aug 2022 11:30:00 +0900<![CDATA[여성 요실금 치료 위한 Graminex® 꽃가루 추출물, 임상 시험서 긍정적 결과 도출]]>https://www.newswire.co.kr/newsRead.php?no=948931Tue, 02 Aug 2022 11:30:00 +0900<![CDATA[Graminex L.L.C. Receives NNHPD Health Canada Approval for PollenBerry®]]>https://www.newswire.co.kr/newsRead.php?no=886104Fri, 05 Apr 2019 10:40:00 +0900<![CDATA[그래미넥스의 폴렌베리, 캐나다 보건부 NNHPD 승인 획득]]>https://www.newswire.co.kr/newsRead.php?no=886105Fri, 05 Apr 2019 10:40:00 +0900<![CDATA[Graminex® LLC successfully challenges Serelys’ patents for use of pollen extracts in treating women's PMS and menopausal symptoms]]>https://www.newswire.co.kr/newsRead.php?no=873435Fri, 03 Aug 2018 11:35:00 +0900<![CDATA[그래미넥스, 여성의 PMS 및 갱년기 증후군 치료에 꽃가루 추출물 사용 위한 세렐리스의 특허출원 거절 결정 환영]]>https://www.newswire.co.kr/newsRead.php?no=873436Fri, 03 Aug 2018 11:35:00 +0900<![CDATA[GRAMINEX L.L.C. expands its partnership with IDIPharma after clinical study publication.]]>https://www.newswire.co.kr/newsRead.php?no=858845Tue, 31 Oct 2017 13:40:00 +0900<![CDATA[그래미넥스, 임상시험 완료 후 IDI파마와의 제휴 확대]]>https://www.newswire.co.kr/newsRead.php?no=858846Tue, 31 Oct 2017 13:40:00 +0900<![CDATA[GRAMINEX L.L.C. Opens New Office in Seoul, Korea, Graminex Korea Co., Ltd.]]>https://www.newswire.co.kr/newsRead.php?no=855086Fri, 25 Aug 2017 15:55:00 +0900<![CDATA[그래미넥스, 서울 사무소 그래미넥스 코리아 신설]]>https://www.newswire.co.kr/newsRead.php?no=855087Fri, 25 Aug 2017 15:55:00 +0900<![CDATA[Graminex L.L.C. Receives NNHPD Health Canada Approval for PollenAid® and Prostanex®]]>https://www.newswire.co.kr/newsRead.php?no=854026Wed, 02 Aug 2017 14:55:00 +0900<![CDATA[그래미넥스, 폴렌에이드 및 프로스타넥스의 NNHPD캐나다 보건부 인증 획득]]>https://www.newswire.co.kr/newsRead.php?no=854027Wed, 02 Aug 2017 14:55:00 +0900